Sorry, this entry is only available in Polish.
Powiązane
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
SK&S advised Heineken International B.V. on the acquisition of the shares in Grupa Żywiec S.A.
SK&S advised Heineken International B.V. in connection with its approx. PLN 1.66 billion (approx. EUR 347 million) acquisition of the…
26 Jan 2023
SK&S Advised Velocity Clinical Research on the acquisition of KO-MED Clinical Centers
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
14 Feb 2024
SK&S advised the Unilin group, part of the Mohawk Group, on the acquisition of shares in a subsidiary of LENTEX S.A.
SK&S’ transaction team advised the Unilin group, part of the US-based Mohawk Group, in its acquisition of a 100% stake…
24 Nov 2022
SK&S advised the Briand Groupe in the cross-border acquisition of the Astron Group
SK&S’ Project Team advised the French Briand Groupe on the Polish aspects of its acquisition of the Astron Group from…
14 Mar 2022